Connect your AI

Intuitive Surgical ISRG Financing Cash Flow

Financing Cash Flow at other companies

Johnson & JohnsonJNJ

$530M-94.9%

StrykerSYK

-$1.51B-160%

NovantaNOVT

-$40.12M+6.1%

Pulmonx CorporationLUNG

$2.03M+205%

PROCEPT BioRobotics CorporationPRCT

$222K-82.9%

MedtronicMDT

-$888M+33.9%

Other financials

Income statement

Revenue$2.8B+23.0%

Gross profit$1.8B+25.6%

Operating income$855.3M+48.0%

Net income$821.5M+17.6%

EPS (diluted)$2.28+18.7%

Balance sheet

Cash & equivalents$2.1B-21.6%

Total debt$170.9M+17.1%

Total equity$17.5B+2.2%

Total assets$20.1B+4.6%

Cash flow

Operating cash flow$911.9M+56.8%

CapEx$103.3M-11.4%

Free cash flow$808.6M+73.9%

Valuation

Market cap$140.84B-21.2%

P/E47.3×-21.3×

P/S13.3×-6.2×

Profitability

Gross margin66.3%-0.8pp

Operating margin30.5%+2.3pp

Net margin28.2%-0.3pp

FCF margin26.8%+6.8pp

Returns & leverage

Return on equity17.2%+1.3pp

Debt / equity0×0.0×

Current ratio4.6×-0.4×

Where this comes from

Reported directly by Intuitive Surgical in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Intuitive Surgical’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Intuitive Surgical's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Intuitive Surgical's financing cash flow?: Intuitive Surgical (ISRG) reported financing cash flow of -$1.35B in Q1 2026.
How has Intuitive Surgical's financing cash flow changed year-over-year?: Intuitive Surgical's financing cash flow decreased by 474.1% year-over-year, from -$235.8M to -$1.35B.
What is the long-term trend for Intuitive Surgical's financing cash flow?: Over 3 years (2021 to 2025), Intuitive Surgical's financing cash flow has grown at a 280.2% compound annual growth rate (CAGR), from $43M to -$2.36B.
What does financing cash flow mean?: Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.